These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9306616)

  • 1. Interaction of fucoidan with proteases and inhibitors of coagulation and fibrinolysis.
    Minix R; Doctor VM
    Thromb Res; 1997 Sep; 87(5):419-29. PubMed ID: 9306616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride.
    Lang D; Williams T; Phillips A; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2004; 29(4):269-75. PubMed ID: 15726889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fucoidan during activation of human plasminogen.
    Doctor VM; Hill C; Jackson GJ
    Thromb Res; 1995 Aug; 79(3):237-47. PubMed ID: 8533120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator.
    Muneer E; Bell J; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2000; 25(2):137-43. PubMed ID: 11112095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of native fucoidan, sulfated fucoidan, heparin and 6-aminohexanoic acid on the activation of glutamic-plasminogen by urokinase: role of NaCl.
    Hall G; Lang D; Qiu X; Doctor V
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):277-81. PubMed ID: 16651870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator.
    Bell J; Duhon S; Doctor VM
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):229-34. PubMed ID: 12695744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A; Shizume K; Cho M; Takada Y
    Thromb Res; 1987 Feb; 45(4):371-81. PubMed ID: 2437668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 6-aminohexanoic acid and fucoidan on the activation of glutamic plasminogen by streptokinase.
    Harris G; Doctor VM
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):355-9. PubMed ID: 12032402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
    Church FC; Meade JB; Treanor RE; Whinna HC
    J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
    Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
    Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin.
    Patston PA; Schapira M
    Blood; 1994 Aug; 84(4):1164-72. PubMed ID: 8049432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation-associated enhancement of fibrinolytic activity via a neutralization of PAI-1 activity.
    Urano T; Ihara H; Suzuki Y; Takada Y; Takada A
    Semin Thromb Hemost; 2000; 26(1):39-42. PubMed ID: 10805280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T; Yamauchi T; Horie M; Nagumo T; Suzuki H
    Thromb Res; 2000 Sep; 99(6):623-34. PubMed ID: 10974349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by tissue plasminogen activator.
    Andrade-Gordon P; Strickland S
    J Biol Chem; 1989 Sep; 264(26):15177-81. PubMed ID: 2504719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
    Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin.
    Silverstein RL; Harpel PC; Nachman RL
    J Biol Chem; 1986 Jul; 261(21):9959-65. PubMed ID: 2942536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.